Liraglutide studies: 1,219 papers with results
Page 11 of 25
- A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
Alves C · Diabetes research and clinical practice · 2012
Systematic review · 3 results
- Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials.
Iqbal J · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
Systematic review · 28 results
- Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.
Tsapas A · Diabetes, obesity & metabolism · 2021
Systematic review · 7 results
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.
Potts JE · PloS one · 2015
Systematic review · 3 results
- Glucagon-like peptide analogues for type 2 diabetes mellitus.
Shyangdan DS · The Cochrane database of systematic reviews · 2011
Systematic review · 11 results
- Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.
Karakasis P · Metabolism: clinical and experimental · 2025
Systematic review · 23 results
- Adverse drug reactions of GLP-1 agonists: A systematic review of case reports.
Shetty R · Diabetes & metabolic syndrome · 2022
Systematic review · 30 results
- Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.
Zhu J · The lancet. Diabetes & endocrinology · 2020
Systematic review · 13 results
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.
Mantovani A · Diabetes & metabolism · 2020
Systematic review · 2 results
- Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.
Monami M · European journal of endocrinology · 2009
Systematic review · 9 results
- Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis.
Zhang YS · Frontiers in endocrinology · 2021
Systematic review · 2 results
- Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
Cheng L · Diabetes/metabolism research and reviews · 2019
Systematic review · 3 results
- Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis.
Souza M · Hepatology (Baltimore, Md.) · 2025
Systematic review · 9 results
- Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.
Singh S · Diabetes, obesity & metabolism · 2017
Systematic review · 2 results
- A meta-analysis of placebo-controlled clinical trials assessing the efficacy and safety of incretin-based medications in patients with type 2 diabetes.
Fakhoury WK · Pharmacology · 2010
Systematic review · 1 result
- Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of randomized clinical trials.
Monami M · Experimental diabetes research · 2011
Systematic review · 4 results
- Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis.
Sun F · Journal of diabetes research · 2015
Systematic review · 6 results
- Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.
Khera R · Gastroenterology · 2018
Systematic review · 9 results
- Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis.
Berg S · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
Systematic review · 5 results
- Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis.
Park J · The Journal of clinical endocrinology and metabolism · 2023
Systematic review · 10 results
- Mild renal impairment and the efficacy and safety of liraglutide.
Davidson JA · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2011
Systematic review · 9 results
- Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.
Simental-Mendía LE · British journal of clinical pharmacology · 2021
Systematic review · 2 results
- Diabetes drugs for nonalcoholic fatty liver disease: a systematic review.
Blazina I · Systematic reviews · 2019
Systematic review · 5 results
- Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhang F · Journal of diabetes · 2015
Systematic review · 7 results
- Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
Goldberg A · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024
Systematic review · 2 results
- A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo.
Scott DA · Diabetes, obesity & metabolism · 2013
Systematic review · 5 results
- Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
Muñoz-Jiménez M · Dementia and geriatric cognitive disorders · 2020
Systematic review · 2 results
- Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program.
Henry RR · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2011
Systematic review · 4 results
- Risk of Malignant Neoplasia with Glucagon-Like Peptide-1 Receptor Agonist Treatment in Patients with Type 2 Diabetes: A Meta-Analysis.
Liu Y · Journal of diabetes research · 2019
Systematic review · 6 results
- GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.
Esposito K · Current medical research and opinion · 2011
Systematic review · 7 results
- Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Dimitrios P · Current diabetes reviews · 2020
Systematic review · 10 results
- Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.
Ismaiel A · International journal of obesity (2005) · 2025
Systematic review · 19 results
- Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis.
Mearns ES · Diabetic medicine : a journal of the British Diabetic Association · 2015
Systematic review · 4 results
- Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines.
Dong Z · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2017
Systematic review · 3 results
- Effects of GLP-1 receptor agonists on neurological complications of diabetes.
García-Casares N · Reviews in endocrine & metabolic disorders · 2023
Systematic review · 6 results
- A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.
Lee K · General hospital psychiatry · 2022
Systematic review · 6 results
- Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis.
Sun F · Endocrine · 2015
Systematic review · 9 results
- Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis.
Li M · Sleep · 2025
Systematic review · 20 results
- Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.
Avgerinos I · Diabetes, obesity & metabolism · 2021
Systematic review · 6 results
- Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials.
Guo H · Obesity pillars · 2025
Systematic review · 18 results
- A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
Hu EH · Medicina (Kaunas, Lithuania) · 2024
Systematic review · 14 results
- Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.
Zaazouee MS · Diabetes & metabolic syndrome · 2022
Systematic review · 8 results
- Comparative effectiveness of multiple different treatment regimens for nonalcoholic fatty liver disease with type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis of randomised controlled trials.
Deng M · BMC medicine · 2023
Systematic review · 8 results
- Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis.
Konwar M · International journal of clinical practice · 2022
Systematic review · 24 results
- Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis.
Inoue H · British journal of clinical pharmacology · 2019
Systematic review · 4 results
- Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials.
Mannucci E · Advances in therapy · 2017
Systematic review · 2 results
- Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
Li Z · PloS one · 2016
Systematic review · 9 results
- Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials.
Zhang Y · Bone · 2025
Systematic review · 4 results
- Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies.
Bagepally BS · BMJ open diabetes research & care · 2020
Systematic review · 6 results
- Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis.
Gray LJ · Diabetes, obesity & metabolism · 2015
Systematic review · 1 result